HU171777B - Sposob poluchenija analogov 16-geterociklicheskij-oksi-17,18,19,20-tetranor-, 15-geterociklicheskij-16,17,18,19,20-pentanor-, 16-geterociklicheskij-17,18,19,20-tetranor- i 17-geterociklicheskij-18,19,20, trinor-prostaglandina - Google Patents
Sposob poluchenija analogov 16-geterociklicheskij-oksi-17,18,19,20-tetranor-, 15-geterociklicheskij-16,17,18,19,20-pentanor-, 16-geterociklicheskij-17,18,19,20-tetranor- i 17-geterociklicheskij-18,19,20, trinor-prostaglandinaInfo
- Publication number
- HU171777B HU171777B HU73IE00000590A HUIE000590A HU171777B HU 171777 B HU171777 B HU 171777B HU 73IE00000590 A HU73IE00000590 A HU 73IE00000590A HU IE000590 A HUIE000590 A HU IE000590A HU 171777 B HU171777 B HU 171777B
- Authority
- HU
- Hungary
- Prior art keywords
- heterocyclic
- pentanor
- tetranor
- trinor
- prostaglandins
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4465272A GB1428137A (en) | 1972-09-27 | 1972-09-27 | Prostanoic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HU171777B true HU171777B (hu) | 1978-03-28 |
Family
ID=10434217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU73IE00000590A HU171777B (hu) | 1972-09-27 | 1973-09-25 | Sposob poluchenija analogov 16-geterociklicheskij-oksi-17,18,19,20-tetranor-, 15-geterociklicheskij-16,17,18,19,20-pentanor-, 16-geterociklicheskij-17,18,19,20-tetranor- i 17-geterociklicheskij-18,19,20, trinor-prostaglandina |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US3931206A (hu) |
| JP (1) | JPS49100071A (hu) |
| AR (1) | AR207550A1 (hu) |
| AT (1) | AT340610B (hu) |
| BE (1) | BE805358A (hu) |
| CA (1) | CA1037033A (hu) |
| CH (3) | CH597175A5 (hu) |
| CS (3) | CS178893B2 (hu) |
| DD (1) | DD107899A5 (hu) |
| DE (1) | DE2348632A1 (hu) |
| EG (1) | EG11278A (hu) |
| ES (5) | ES419143A1 (hu) |
| FR (1) | FR2200014B1 (hu) |
| GB (1) | GB1428137A (hu) |
| HU (1) | HU171777B (hu) |
| IE (1) | IE38241B1 (hu) |
| IL (1) | IL43248A (hu) |
| NL (1) | NL7313322A (hu) |
| NO (1) | NO145380C (hu) |
| PL (2) | PL96782B1 (hu) |
| SE (3) | SE424859B (hu) |
| SU (1) | SU648088A3 (hu) |
| YU (2) | YU254573A (hu) |
| ZA (1) | ZA737357B (hu) |
| ZM (1) | ZM15873A1 (hu) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3953502A (en) | 1973-01-31 | 1976-04-27 | Imperial Chemical Industries Limited | Cyclopentane derivatives |
| GB1431561A (en) * | 1973-01-31 | 1976-04-07 | Ici Ltd | Cyclopentane derivatives |
| GB1507211A (en) * | 1975-02-14 | 1978-04-12 | Ono Pharmaceutical Co | Prostaglandin analogues |
| DE2524955C3 (de) | 1975-06-05 | 1981-12-03 | Hoechst Ag, 6000 Frankfurt | Neue Thienyl-Prostaglandine und Verfahren zu ihrer Herstellung |
| US4464532A (en) * | 1979-07-31 | 1984-08-07 | Nippon Kayaku Kabushiki Kaisha | Intermediates of 7-alkoxycarbonyl-6,8-dimethyl-4-hydroxymethyl-1-phthalazone |
| US5545665A (en) | 1993-12-28 | 1996-08-13 | Allergan | Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
| US6110903A (en) * | 1997-03-07 | 2000-08-29 | Sankyo Company Ltd. | Benzimidazole inhibitors of fructose 1,6-bisphosphatase |
| AU6691798A (en) * | 1997-03-07 | 1998-09-22 | Metabasis Therapeutics, Inc. | Novel indole and azaindole inhibitors of fructose-1,6-bisphosphatase |
| US6284748B1 (en) * | 1997-03-07 | 2001-09-04 | Metabasis Therapeutics, Inc. | Purine inhibitors of fructose 1,6-bisphosphatase |
| AU761267C (en) * | 1998-09-09 | 2007-08-09 | Metabasis Therapeutics, Inc. | Novel heteroaromatic inhibitors of fructose 1,6-bisphosphatase |
| NZ513825A (en) * | 1999-03-05 | 2001-09-28 | Procter & Gamble | C 16 unsaturated FP-selective prostaglandins analogs |
| JP2003519154A (ja) * | 1999-12-22 | 2003-06-17 | メタバシス・セラピューティクス・インコーポレイテッド | 新規なビスアミダートホスホネートプロドラッグ |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US7563774B2 (en) | 2000-06-29 | 2009-07-21 | Metabasis Therapeutics, Inc. | Combination of FBPase inhibitors and antidiabetic agents useful for the treatment of diabetes |
| US20090148527A1 (en) * | 2007-12-07 | 2009-06-11 | Robinson Michael R | Intraocular formulation |
| CN101005847A (zh) * | 2004-08-18 | 2007-07-25 | 症变治疗公司 | 果糖1,6－双磷酸酶的新颖噻唑类抑制剂 |
| CN113912539B (zh) * | 2021-12-13 | 2022-03-11 | 山东国邦药业有限公司 | 一种环丙羧酸的合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3836578A (en) * | 1965-12-16 | 1974-09-17 | Kemiska Inst | Prostanoic acid derivatives |
| US3726909A (en) * | 1970-10-16 | 1973-04-10 | P Beal | 9,15-dihydroxy prostanoic acids and esters thereof |
-
1972
- 1972-09-27 GB GB4465272A patent/GB1428137A/en not_active Expired
-
1973
- 1973-01-01 AR AR250278A patent/AR207550A1/es active
- 1973-09-12 IE IE1623/73A patent/IE38241B1/xx unknown
- 1973-09-14 US US05/397,327 patent/US3931206A/en not_active Expired - Lifetime
- 1973-09-17 ZA ZA737357*A patent/ZA737357B/xx unknown
- 1973-09-18 IL IL43248A patent/IL43248A/en unknown
- 1973-09-25 CA CA181,903A patent/CA1037033A/en not_active Expired
- 1973-09-25 HU HU73IE00000590A patent/HU171777B/hu unknown
- 1973-09-26 BE BE136083A patent/BE805358A/xx not_active IP Right Cessation
- 1973-09-26 YU YU02545/73A patent/YU254573A/xx unknown
- 1973-09-26 NO NO3779/73A patent/NO145380C/no unknown
- 1973-09-26 SU SU731967274A patent/SU648088A3/ru active
- 1973-09-26 SE SE7313112A patent/SE424859B/xx unknown
- 1973-09-26 EG EG374/73A patent/EG11278A/xx active
- 1973-09-26 FR FR7334504A patent/FR2200014B1/fr not_active Expired
- 1973-09-27 CH CH1386573A patent/CH597175A5/xx not_active IP Right Cessation
- 1973-09-27 AT AT832673A patent/AT340610B/de not_active IP Right Cessation
- 1973-09-27 DD DD173723A patent/DD107899A5/xx unknown
- 1973-09-27 JP JP48108876A patent/JPS49100071A/ja active Pending
- 1973-09-27 CH CH1363276A patent/CH595341A5/xx not_active IP Right Cessation
- 1973-09-27 CS CS7300006649A patent/CS178893B2/cs unknown
- 1973-09-27 NL NL7313322A patent/NL7313322A/xx not_active Application Discontinuation
- 1973-09-27 PL PL1973185293A patent/PL96782B1/pl unknown
- 1973-09-27 CS CS7500003523A patent/CS178894B2/cs unknown
- 1973-09-27 DE DE19732348632 patent/DE2348632A1/de not_active Withdrawn
- 1973-09-27 CS CS7500003524A patent/CS178895B2/cs unknown
- 1973-09-27 PL PL1973165466A patent/PL97363B1/pl unknown
- 1973-09-27 ES ES419143A patent/ES419143A1/es not_active Expired
- 1973-09-27 CH CH1363176A patent/CH596164A5/xx not_active IP Right Cessation
- 1973-09-27 ZM ZM158/73A patent/ZM15873A1/xx unknown
-
1976
- 1976-01-02 ES ES444047A patent/ES444047A1/es not_active Expired
- 1976-01-02 ES ES444044A patent/ES444044A1/es not_active Expired
- 1976-01-02 ES ES444046A patent/ES444046A1/es not_active Expired
- 1976-01-02 ES ES444045A patent/ES444045A1/es not_active Expired
- 1976-10-12 SE SE7611315A patent/SE7611315L/xx unknown
- 1976-10-12 SE SE7611316A patent/SE7611316L/xx unknown
-
1980
- 1980-10-20 YU YU02685/80A patent/YU268580A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPS5387333A (en) | Process for preparing acyldiamine | |
| YU254979A (en) | Process for preparing new 3,4-dihydrocarbostyryl-derivatives | |
| JPS52106898A (en) | Process for preparing 55oxoo88alkyll 5*88dihydride*2*33d**66carboxylate | |
| HU171777B (hu) | Sposob poluchenija analogov 16-geterociklicheskij-oksi-17,18,19,20-tetranor-, 15-geterociklicheskij-16,17,18,19,20-pentanor-, 16-geterociklicheskij-17,18,19,20-tetranor- i 17-geterociklicheskij-18,19,20, trinor-prostaglandina | |
| CS185216B2 (en) | Process for preparing dimethylethere | |
| CH614188A5 (en) | Process for the preparation of novel aminophenylethanolamines | |
| YU128373A (en) | Process for preparing 6-phenyl-substituted 3-methyl-4-amino-5h-1,2,4-triazine-5-ones | |
| EG10850A (en) | Process for the preparation of 1-hydroxy-pyridones | |
| HU175725B (hu) | Sposob poluchenija tetrakhlor-izoftalonitrila | |
| JPS52122349A (en) | Process for preparing tntermediate of 155substituteddomegaa pentanoprostagladines | |
| KR780000072B1 (en) | Process for preparing new 2-alkylamino-dihydropyridines | |
| YU35884B (en) | Process for preparing 1-ethyl-imidazoles | |
| IL43385A0 (en) | Process for preparing perchloro-methylmercaptane | |
| YU238572A (en) | Process for preparing n-(-ethyl-delta-pyrrolidyl-methyl)-2-methoxy-5-sulfamidobenzamide | |
| KR780000029B1 (en) | Process for preparing novel benzyl-pyrimidines | |
| HU171945B (hu) | Sposob poluchenija slozhnykh p-bifenilil-ehfirov 16-fenil-11,15-tetragidropiraniloksi-omega-tetranor-prostaglandina | |
| YU82473A (en) | Process for preparing novel phenyl-formamides | |
| YU36303B (en) | Process for preparing tetramisol | |
| KR780000156B1 (en) | Process for preparing 150 160-methylen -oestren-17-36 | |
| EG11435A (en) | Process for preparation of n(1-ethyl-2-pyrrolidylmethyl)-2-methoxy-5-ethylsulphonyl-benzamide | |
| YU36020B (en) | Process for preparing m-dioxane-5-methylamine | |
| GB1403143A (en) | Process for the preparation of heptamethyleneimine | |
| IL42308A0 (en) | New process for the preparation of 2-methoxy-5-sulfamoyl benzoyl-n-ethyl-2-pyrrolidine-methylamine | |
| YU212873A (en) | Process for preparing bicyclomycin | |
| YU35572B (en) | Process for preparing 2-amino-benzylamines |